Randomized, double‐blind, 6‐week non‐inferiority study of lurasidone and risperidone for the treatment of schizophrenia

AIM: The aim of the present study was to evaluate the efficacy and safety of lurasidone for the treatment of Chinese schizophrenic patients. METHODS: Hospitalized schizophrenia patients aged 18–65 were randomized to 6 weeks of double‐blind, double‐dummy, flexible‐dose treatment with lurasidone (40 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yuan, Shi, Jianguo, Wang, Lili, Zhang, Xia, Tan, Yunlong, Zhao, Jingyuan, Ning, Yuping, Xie, Shiping, Liu, Xuejun, Liu, Qi, Li, Keqing, Wang, Xiaoliang, Li, Lehua, Xu, Xiufeng, Deng, Wei, Luo, Xiaoyan, Wang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317929/
https://www.ncbi.nlm.nih.gov/pubmed/31823444
http://dx.doi.org/10.1111/pcn.12965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317929/
https://www.ncbi.nlm.nih.gov/pubmed/31823444
http://dx.doi.org/10.1111/pcn.12965

Ejemplares similares